Sethna et al., Lung-tumor directed gene therapy using neuroendocrine and lung-tissue specific promoters, 1997, vol. 38, pp. 379.* |
Peri et al., Tissue-specific expression of the gene coding for human clara cell 10-kD protein, a phospholipase A2-inhibitory protein, 1993, The Journal of Clinical Investigation, vol. 92, pp. 2099-2109.* |
Shuman et al., Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate, 1997, The Journal of Urology, vol. 157, pp. 552-555.* |
Manyak et al., Uteroglobin inhibition of prostate adenocarcinoma invasion in vitro: A new class of tumor suppressor genes, 1995, The Journal Urology, vol. 153, pp. 969.* |
Verma et al., Gene therapy-promises, problems and prospects, 1997, Nature, vol. 389, pp. 239-242.* |
Chiu et al., optimizing energy potenetials for success in protein tertiary structure prediction, 1998, Folding & Design, vol. 3, pp. 223-228.* |
Anderson et al., Human gene therapy, 1998, Nature, vol. 392, pp. 25-30.* |
Vile et al., Cancer gene therapy: hard lessons and new courses, 2000, Gene Therapy, vol. 7, pp. 2-8.* |
Gomez-Navarro et al., Gene therapy for cancer, 1999, European Journal of Cancer, vol. 35, pp. 867-885.* |
Bodey et al., Failure of cancer vaccines: The significant limitations of this approach to immunotherapy, 2000, Anticancer Research, vol. 20, pp. 2665-2676.* |
Hill, Richard P., Chapter 11, Metastasis, pp. 178-195 in The Basic Science of Oncology, Tannock et al., Eds., McGraw-Hill, N.Y. (1992). |
Aznavoorian, Sadie et al., “Molecular Aspects of Tumor Cell Invasion and Metastasis,” Cancer, 1993, 71(4), 1368-1383. |
Singh, Gurmukh et al., “Amino-acid and cDNA nucleotide sequences of human Clara cell 10 kDa protein,” BBA, 1988, 950, 329-337. |
Miele, Lucio et al., “Uteroglobin: Structure, Molecular Biology, and New Perspectives on Its Function as a Phospholipase A2 Inhibitor,” Endocrine Reviews, 1987, 8(4), 474-90. |
Nieto, A. et al., “Purification and Quternary Structure of the Hormonally Induced Protein Uteroglobin,” Arch. Biochem. Biophys., 1977, 180, 82-92. |
Mantile, Giuditta et al., “Human Clara Cell 10-kDa Protein Is the Counterpart of Rabbit Uteroglobin,” J. Biol. Chem., 1993, 268(27), 20343-20351. |
Miele, Lucio et al., “High Level Bacterial Expression of Uteroglobin, a Dimeric Eukaryotic Protein with Two Interchain Disulfide Bridges, in Its Natural Quaternary Structure,” J. Biol. Chem., 1990, 265(11), 6427-35. |
Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1989). |
Arcone, Rosaria et al., “Structural characterization of a biologically active human lipocortin 1 expressed in Eschericia coli,” Eur. J. Biochem., 1993, 211, 347-55. |
Cirino, G. et al., “Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1,” British J. Pharmacol., 1993, 108, 573-574. |
Bastian, Boris Christoph et al., “Inhibition of Human Skin Phospholipase A2 by “Lipocortins” Is an Indirect Effect of Substrate/Lipocortin Interaction,” J. Invest. Dermatol., 1993, 101(3), 359-63. |
Ritter, Mary A. et al., Eds., Monoclonal Antibodies—Production, Engineering and Clinical Applications, Cambridge University Press, Cambridge, UK (1995). |
Budavari, Susan et al., Eds., The Merck Index, 11th Ed., Merck & Co., Inc., Rahway, N.J. (1989). |
Gilman, Alfred Goodman et al., Eds., Goodman and Gilman's: The Pharmacological Bases of Therapeutics, 8th Ed., Pergamon Press, U.S.A. (1990). |
Remington's Pharmaceutical Sciences, 17th Ed., Mack Publishing Co., Easton, PA (1990). |
Goldenberg, David M., Ed., Cancer Therapy With Radiolabeled Antibodies, CRC Press, Boca Raton, FL (1995). |
Stone, Kenneth R. et al., “Isolation of a Human Prostate Carcinoma Cell Line (DU 145),” Int. J. Cancer, 1978, 21, 274-281. |
Horoszewicz, Julius S. et al., “LNCaP Model of Human Prostatic Carcinoma,” Cancer Res., 1983, 43, 1809-18. |
Kaighn, M.E. et al., “Establishment and Characterization of Human Prostatic Carcinoma Cell Line (PC-3),” Invest. Urol., 1979, 17(1), 16-23. |
Hzumi, Tatsuo et al., “Establishment of a New Prostatic Carcinoma Cell Line (TSU-PR1),” J. Urology, 1987, 137, 1304-1306. |
Albini, A. et al., “A Rapid in Vitro Assay for Quantitating the Invasive Potential of Tumor Cells,” Cancer Research, 1987, 47, 3239-3245. |
Leyton, J. et al., “Recombinant Human Uteroglobin Inhibits the in Vitro Invasiveness of Human Metastatic Prostate Tumor Cells and the Releaase of Arachidonic Acid Stimulated by Fibroblast-conditioned Medium,” Cancer Research, 1994, 54, 3696-3699. |
Frandson, T.L. et al., “Assays for the Study of Human Cancer Cell Invasion and Metastasis,” Fibrinolysis, 1992, 6 (Supp. 4), 71-76. |
Manyak, Michael J. et al., “Expression of a Uteroglobin-Like Protein in Human Prostate,” J. Urology, 1988, 140, 176-182. |
Cerbón et al., J. Steroid Biochem., 36: 1-6 (1990). |
López de Haro et al., Febs Letters, 232: 351-353 (1988). |
Aumuller et al., Histochemistry, 83: 413-417 (1985). |
Tibes et al., Expert Opin. Invest. Drugs, 6: 279-298, (1997). |
Dannhorn et al., J. Immunol. Meth., 119: 223-230 (1989). |
Osband et al., Immunology Today, 11: 193-195 (1990). |
Mayer et al., Expert Opin. Invest. Drugs, 5: 535-554, (1996). |
Leyton et al., Proc. Amer. Assoc. Canc. Res. 35: 280 (1994). |
Broers et al., Laboratory Investigation, 66(3): 337-346 (1992). |
Miyamoto et al., J. Urology, 149: 1015-1019 (May 1993). |
Jensen et al., Int. J. Cancer, 58: 629-637 (1994). |
Linnoila et al., A.J.C.P., 97(2): 233-243 (Feb. 1992). |
Peri et al., J. Clinical Inv., 92: 2099-2109 (Nov. 1993). |
Morgan et al., Annu. Rev. Biochem., 62: 191-217 (1993). |
Tolstoshev, Annu. Rev. Pharmacol. Toxicol., 32: 573-96 (1993). |